Exact Mass: 569.1910392
Exact Mass Matches: 569.1910392
Found 288 metabolites which its exact mass value is equals to given mass value 569.1910392
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Decarbamoylnovobiocin
A hydroxycoumarin that is novobiocin lacking the carbamoyl group from position 3 on the hexose ring.
Aklavin
D000970 - Antineoplastic Agents D007155 - Immunologic Factors
Firsocostat
Aklavin
Emricasan
Ibritumomab tiuxetan
Guanosine, 2'-deoxy-N-(7,8,9,10-tetrahydro-7,8,9-trihydroxybenzo(a)pyren-10-yl)-
Astin C
Astin C (Asterin) is a cyclic pentapeptide with anticancer and anti-inflammatory properties[1]. Astin C (Asterin) is a cyclic pentapeptide with anticancer and anti-inflammatory properties[1]. Astin C (Asterin) is a cyclic pentapeptide with anticancer and anti-inflammatory properties[1].
C25H33Cl2N5O6_17,18-Dichloro-3,13-diethyl-6-(hydroxymethyl)-9-phenyldodecahydropyrrolo[1,2-d][1,4,7,10,13]pentaazacyclohexadecine-1,4,7,11,14(8H)-pentone
Ala Met Trp Tyr
C28H35N5O6S (569.2307930000001)
Ala Met Tyr Trp
C28H35N5O6S (569.2307930000001)
Ala Trp Met Tyr
C28H35N5O6S (569.2307930000001)
Ala Trp Tyr Met
C28H35N5O6S (569.2307930000001)
Ala Tyr Met Trp
C28H35N5O6S (569.2307930000001)
Ala Tyr Trp Met
C28H35N5O6S (569.2307930000001)
Cys Asp Phe Trp
Cys Asp Trp Phe
Cys Glu Arg Tyr
C23H35N7O8S (569.2267710000001)
Cys Glu Tyr Arg
C23H35N7O8S (569.2267710000001)
Cys Phe Asp Trp
Cys Phe Trp Asp
Cys Met Met Trp
Cys Met Trp Met
Cys Arg Glu Tyr
C23H35N7O8S (569.2267710000001)
Cys Arg Tyr Glu
C23H35N7O8S (569.2267710000001)
Cys Val Trp Tyr
C28H35N5O6S (569.2307930000001)
Cys Val Tyr Trp
C28H35N5O6S (569.2307930000001)
Cys Trp Asp Phe
Cys Trp Phe Asp
Cys Trp Met Met
Cys Trp Val Tyr
C28H35N5O6S (569.2307930000001)
Cys Trp Tyr Val
C28H35N5O6S (569.2307930000001)
Cys Tyr Glu Arg
C23H35N7O8S (569.2267710000001)
Cys Tyr Arg Glu
C23H35N7O8S (569.2267710000001)
Cys Tyr Val Trp
C28H35N5O6S (569.2307930000001)
Cys Tyr Trp Val
C28H35N5O6S (569.2307930000001)
Asp Cys Phe Trp
Asp Cys Trp Phe
Asp Phe Cys Trp
Asp Phe Trp Cys
Asp Ser Trp Tyr
Asp Ser Tyr Trp
Asp Trp Cys Phe
Asp Trp Phe Cys
Asp Trp Ser Tyr
Asp Trp Tyr Ser
Asp Tyr Ser Trp
Asp Tyr Trp Ser
Glu Cys Arg Tyr
C23H35N7O8S (569.2267710000001)
Glu Cys Tyr Arg
C23H35N7O8S (569.2267710000001)
Glu Met Gln Tyr
Glu Met Tyr Gln
Glu Gln Met Tyr
Glu Gln Tyr Met
Glu Arg Cys Tyr
C23H35N7O8S (569.2267710000001)
Glu Arg Tyr Cys
C23H35N7O8S (569.2267710000001)
Glu Tyr Cys Arg
C23H35N7O8S (569.2267710000001)
Glu Tyr Met Gln
Glu Tyr Gln Met
Glu Tyr Arg Cys
C23H35N7O8S (569.2267710000001)
Phe Cys Asp Trp
Phe Cys Trp Asp
Phe Asp Cys Trp
Phe Asp Trp Cys
Phe Met Ser Trp
C28H35N5O6S (569.2307930000001)
Phe Met Trp Ser
C28H35N5O6S (569.2307930000001)
Phe Ser Met Trp
C28H35N5O6S (569.2307930000001)
Phe Ser Trp Met
C28H35N5O6S (569.2307930000001)
Phe Trp Cys Asp
Phe Trp Asp Cys
Phe Trp Met Ser
C28H35N5O6S (569.2307930000001)
Phe Trp Ser Met
C28H35N5O6S (569.2307930000001)
His His Asn Tyr
His His Tyr Asn
His Asn His Tyr
His Asn Asn Trp
His Asn Trp Asn
His Asn Tyr His
His Trp Asn Asn
His Tyr His Asn
His Tyr Asn His
Met Ala Trp Tyr
C28H35N5O6S (569.2307930000001)
Met Ala Tyr Trp
C28H35N5O6S (569.2307930000001)
Met Cys Met Trp
Met Cys Trp Met
Met Glu Gln Tyr
Met Glu Tyr Gln
Met Phe Ser Trp
C28H35N5O6S (569.2307930000001)
Met Phe Trp Ser
C28H35N5O6S (569.2307930000001)
Met Met Cys Trp
Met Met Trp Cys
Met Gln Glu Tyr
Met Gln Tyr Glu
Met Ser Phe Trp
C28H35N5O6S (569.2307930000001)
Met Ser Trp Phe
C28H35N5O6S (569.2307930000001)
Met Trp Ala Tyr
C28H35N5O6S (569.2307930000001)
Met Trp Cys Met
Met Trp Phe Ser
C28H35N5O6S (569.2307930000001)
Met Trp Met Cys
Met Trp Ser Phe
C28H35N5O6S (569.2307930000001)
Met Trp Tyr Ala
C28H35N5O6S (569.2307930000001)
Met Tyr Ala Trp
C28H35N5O6S (569.2307930000001)
Met Tyr Glu Gln
Met Tyr Gln Glu
Met Tyr Trp Ala
C28H35N5O6S (569.2307930000001)
Asn His His Tyr
Asn His Asn Trp
Asn His Trp Asn
Asn His Tyr His
Asn Asn His Trp
Asn Asn Trp His
Asn Trp His Asn
Asn Trp Asn His
Asn Tyr His His
Gln Glu Met Tyr
Gln Glu Tyr Met
Gln Met Glu Tyr
Gln Met Tyr Glu
Gln Tyr Glu Met
Gln Tyr Met Glu
Arg Cys Glu Tyr
C23H35N7O8S (569.2267710000001)
Arg Cys Tyr Glu
C23H35N7O8S (569.2267710000001)
Arg Glu Cys Tyr
C23H35N7O8S (569.2267710000001)
Arg Glu Tyr Cys
C23H35N7O8S (569.2267710000001)
Arg Tyr Cys Glu
C23H35N7O8S (569.2267710000001)
Arg Tyr Glu Cys
C23H35N7O8S (569.2267710000001)
Ser Asp Trp Tyr
Ser Asp Tyr Trp
Ser Phe Met Trp
C28H35N5O6S (569.2307930000001)
Ser Phe Trp Met
C28H35N5O6S (569.2307930000001)
Ser Met Phe Trp
C28H35N5O6S (569.2307930000001)
Ser Met Trp Phe
C28H35N5O6S (569.2307930000001)
Ser Trp Asp Tyr
Ser Trp Phe Met
C28H35N5O6S (569.2307930000001)
Ser Trp Met Phe
C28H35N5O6S (569.2307930000001)
Ser Trp Tyr Asp
Ser Tyr Asp Trp
Ser Tyr Trp Asp
Val Cys Trp Tyr
C28H35N5O6S (569.2307930000001)
Val Cys Tyr Trp
C28H35N5O6S (569.2307930000001)
Val Trp Cys Tyr
C28H35N5O6S (569.2307930000001)
Val Trp Tyr Cys
C28H35N5O6S (569.2307930000001)
Val Tyr Cys Trp
C28H35N5O6S (569.2307930000001)
Val Tyr Trp Cys
C28H35N5O6S (569.2307930000001)
Trp Ala Met Tyr
C28H35N5O6S (569.2307930000001)
Trp Ala Tyr Met
C28H35N5O6S (569.2307930000001)
Trp Cys Asp Phe
Trp Cys Phe Asp
Trp Cys Met Met
Trp Cys Val Tyr
C28H35N5O6S (569.2307930000001)
Trp Cys Tyr Val
C28H35N5O6S (569.2307930000001)
Trp Asp Cys Phe
Trp Asp Phe Cys
Trp Asp Ser Tyr
Trp Asp Tyr Ser
Trp Phe Cys Asp
Trp Phe Asp Cys
Trp Phe Met Ser
C28H35N5O6S (569.2307930000001)
Trp Phe Ser Met
C28H35N5O6S (569.2307930000001)
Trp His Asn Asn
Trp Met Ala Tyr
C28H35N5O6S (569.2307930000001)
Trp Met Cys Met
Trp Met Phe Ser
C28H35N5O6S (569.2307930000001)
Trp Met Met Cys
Trp Met Ser Phe
C28H35N5O6S (569.2307930000001)
Trp Met Tyr Ala
C28H35N5O6S (569.2307930000001)
Trp Asn His Asn
Trp Asn Asn His
Trp Ser Asp Tyr
Trp Ser Phe Met
C28H35N5O6S (569.2307930000001)
Trp Ser Met Phe
C28H35N5O6S (569.2307930000001)
Trp Ser Tyr Asp
Trp Val Cys Tyr
C28H35N5O6S (569.2307930000001)
Trp Val Tyr Cys
C28H35N5O6S (569.2307930000001)
Trp Tyr Ala Met
C28H35N5O6S (569.2307930000001)
Trp Tyr Cys Val
C28H35N5O6S (569.2307930000001)
Trp Tyr Asp Ser
Trp Tyr Met Ala
C28H35N5O6S (569.2307930000001)
Trp Tyr Ser Asp
Trp Tyr Val Cys
C28H35N5O6S (569.2307930000001)
Tyr Ala Met Trp
C28H35N5O6S (569.2307930000001)
Tyr Ala Trp Met
C28H35N5O6S (569.2307930000001)
Tyr Cys Glu Arg
C23H35N7O8S (569.2267710000001)
Tyr Cys Arg Glu
C23H35N7O8S (569.2267710000001)
Tyr Cys Val Trp
C28H35N5O6S (569.2307930000001)
Tyr Cys Trp Val
C28H35N5O6S (569.2307930000001)
Tyr Asp Ser Trp
Tyr Asp Trp Ser
Tyr Glu Cys Arg
C23H35N7O8S (569.2267710000001)
Tyr Glu Met Gln
Tyr Glu Gln Met
Tyr Glu Arg Cys
C23H35N7O8S (569.2267710000001)
Tyr His His Asn
Tyr His Asn His
Tyr Met Ala Trp
C28H35N5O6S (569.2307930000001)
Tyr Met Glu Gln
Tyr Met Gln Glu
Tyr Met Trp Ala
C28H35N5O6S (569.2307930000001)
Tyr Asn His His
Tyr Gln Glu Met
Tyr Gln Met Glu
Tyr Arg Cys Glu
C23H35N7O8S (569.2267710000001)
Tyr Arg Glu Cys
C23H35N7O8S (569.2267710000001)
Tyr Ser Asp Trp
Tyr Ser Trp Asp
Tyr Val Cys Trp
C28H35N5O6S (569.2307930000001)
Tyr Val Trp Cys
C28H35N5O6S (569.2307930000001)
Tyr Trp Ala Met
C28H35N5O6S (569.2307930000001)
Tyr Trp Cys Val
C28H35N5O6S (569.2307930000001)
Tyr Trp Asp Ser
Tyr Trp Met Ala
C28H35N5O6S (569.2307930000001)
Tyr Trp Ser Asp
Tyr Trp Val Cys
C28H35N5O6S (569.2307930000001)
5-O-[BIS(4-METHOXYPHENYL)PHENYLMETHYL]-ADENOSINE
5'-O-[Bis(4-methoxyphenyl)phenylmethyl]-adenosine is an adenosine analog. Adenosine analogs mostly act as smooth muscle vasodilators and have also been shown to inhibit cancer progression. Its popular products are adenosine phosphate, Acadesine (HY-13417), Clofarabine (HY-A0005), Fludarabine phosphate (HY-B0028) and Vidarabine (HY-B0277)[1].
Emricasan
COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C471 - Enzyme Inhibitor Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
2,3,5-Tri-O-benzyl-D-arabinofuranose 1-(4-nitrobenzoate)
Motesanib diphosphate
C22H29N5O9P2 (569.1440444000001)
C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors
Bosentan hydrate
D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D065128 - Endothelin Receptor Antagonists C28313 - Endothelin Receptor Antagonist Bosentan hydrate is a competitive and dual antagonist of endothelin-1 (ET) for the ETA and ETB receptors with Ki of 4.7 nM and 95 nM in human SMC, respectively.
2,3,5-TRI-O-BENZYL-1-O-(4-NITROBENZOYL)-D-ALPHA-ARABINOFURANOSE
TERT-BUTYL 4-((6-(2-(QUINOXALINE-2-CARBOXAMIDO)PHENYL)IMIDAZO[2,1-B]THIAZOL-3-YL)METHYL)PIPERAZINE-1-CARBOXYLATE
C30H31N7O3S (569.2208976000001)
Haloperidol-1-hydroxy-2-D-glucuronide
C27H33ClFNO9 (569.1827770000001)
3(2H)-Benzoxazolepropanesulfonic acid, 2-[4-(1,3-dibutyltetrahydro-4,6-dioxo-2-thioxo-5(2H)-pyrimidinylidene)-2-butenylidene]-, sodium salt
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D049408 - Luminescent Agents D011838 - Radiation-Sensitizing Agents > D017319 - Photosensitizing Agents D000890 - Anti-Infective Agents > D000998 - Antiviral Agents D004396 - Coloring Agents > D005456 - Fluorescent Dyes D003879 - Dermatologic Agents
Firsocostat
D004791 - Enzyme Inhibitors C471 - Enzyme Inhibitor Firsocostat (ND-630; GS-0976; NDI-010976) is an acetyl-CoA carboxylase (ACC) inhibitor; inhibits human ACC1 and ACC2 with IC50 values of 2.1 and 6.1 nM, respectively.
(1R,2R,4S)-2-ethyl-2,7-dihydroxy-1-(methoxycarbonyl)-6,11-dioxo-4-{[2,3,6-trideoxy-3-(dimethylazaniumyl)-alpha-L-lyxo-hexopyranosyl]oxy}-1,2,3,4,6,11-hexahydrotetracen-5-olate
Lactonamycin
C28H27NO12 (569.1533182000001)
An organic heterohexacyclic compound isolated from the culture broth of Streptomyces rishiriensis. It is an antibiotic with antibacterial activity.
{3-[(6-(anilinocarbonyl)-5-(4-ethoxyphenyl)-7-methyl-3-oxo-5H-[1,3]thiazolo[3,2-a]pyrimidin-2(3H)-ylidene)methyl]phenoxy}acetic acid
C31H27N3O6S (569.1620482000001)
2-[(1R,8S,14R,15R)-11-hydroxy-15-[(E,2S)-2-hydroxy-3-oxooct-6-enyl]-14-[(E)-oct-6-enyl]-3,5,9-trioxo-4,10-dioxatetracyclo[9.4.0.02,6.08,12]pentadeca-2(6),12-dien-8-yl]acetate
2-[(1R,3S,4aR,9aS)-1-(hydroxymethyl)-6-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(1S)-1-phenylethyl]acetamide
2-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-6-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2-phenylethyl)acetamide
2-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-6-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2-phenylethyl)acetamide
2-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-6-[[4-(trifluoromethyl)phenyl]carbamoylamino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-[(1S)-1-phenylethyl]acetamide
2-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-6-[[4-(trifluoromethyl)phenyl]carbamoylamino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-[(1S)-1-phenylethyl]acetamide
2-[(1S,3R,4aR,9aS)-1-(hydroxymethyl)-6-[[4-(trifluoromethyl)phenyl]carbamoylamino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-[(1S)-1-phenylethyl]acetamide
2-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-6-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(1S)-1-phenylethyl]acetamide
2-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-6-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2-phenylethyl)acetamide
2-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-6-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2-phenylethyl)acetamide
(4-fluorophenyl)-[(1R)-1-(hydroxymethyl)-7-methoxy-1-thiophen-2-ylsulfonyl-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]methanone
2-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-6-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(1S)-1-phenylethyl]acetamide
2-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-6-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(1S)-1-phenylethyl]acetamide
2-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-6-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(1S)-1-phenylethyl]acetamide
2-[(1R,3S,4aR,9aS)-1-(hydroxymethyl)-6-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2-phenylethyl)acetamide
2-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-6-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2-phenylethyl)acetamide
2-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-6-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2-phenylethyl)acetamide
2-[(1S,3R,4aR,9aS)-1-(hydroxymethyl)-6-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2-phenylethyl)acetamide
(4-fluorophenyl)-[(1S)-1-(hydroxymethyl)-7-methoxy-1-thiophen-2-ylsulfonyl-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]methanone
4,7-DI(4-Butoxyphenyl)-6-(3,4-dimethoxyphenyl)-1,2,5-thiadiazolo(3,4-C)pyridine
aclacinomycin T zwitterion
A zwitterion obtained by transfer of a proton from the 5-hydroxy to the tertiary amino group of aclacinomycin T. It is the major microspecies at pH 7.3 (according to Marvin v 6.2.0.).
8,12-diethyl-3-vinylbacteriochlorophyllide d(1-)
A cyclic tetrapyrrole anion that is the conjugate base of 8,12-diethyl-3-vinylbacteriochlorophyllide d, obtained by deprotonation of the carboxy group; major species at pH 7.3.
beta-D-galactosyl-1,3-(N-acetyl-beta-D-glucosaminyl-1,6)-N-acetyl-D-galactosaminyl group
The group obtained by removal of the anomeric hydroxyl group from beta-D-galactosyl-1,3-(N-acetyl-beta-D-glucosaminyl-1,6)-N-acetyl-D-galactosamine.
Aclacinomycin T
An anthracycline that is aklavinone having an alpha-L-rhodosaminyl residue attached at position 4 via a glycosidic linkage.
BI-882370
BI-882370 is a potent and selective RAF kinase inhibitor that binds to the ATP binding site of the kinase positioned in the DFG-out (inactive) conformation of the BRAF kinase. BI-882370 (BI 882370) inhibits the oncogenic BRAFV600E-mutant, the WT BRAF and CRAF kinases with IC50s of 0.4, 0.8, and 0.6 nM, respectively. BI-882370 also inhibits SRC family kinases[1].
2,9-dihydroxy-15-[(5-hydroxy-6-methyloxan-2-yl)oxy]-18-methoxy-6-methyl-17,21-dioxa-6-azahexacyclo[11.10.0.0³,¹¹.0⁴,⁸.0¹⁵,²².0¹⁸,²²]tricosa-1,3,8,10,12-pentaene-7,14,20,23-tetrone
C28H27NO12 (569.1533182000001)
(9r,14s,17s,19s,23r,24s)-23,24-dihydroxy-5-methoxy-12,12-dimethyl-9-(2-methylprop-1-en-1-yl)-16,22-dioxo-10,11-dioxa-8,15,21-triazahexacyclo[12.10.1.0²,⁷.0⁸,²⁵.0¹⁵,²³.0¹⁷,²¹]pentacosa-1(25),2,4,6-tetraen-19-yl acetate
C29H35N3O9 (569.2373180000001)